Polred (487580) IPO Analysis: +300% Day-1 Surge, ₩80B Revenue, Japan 84% Risk & Entry Checklist
Trending · IPO Analysis
Polred (KOSDAQ: 487580) hit the double-limit ceiling (+300%) on its first trading day. The Hyundai Motor spin-off turned baby products company posted ₩80B revenue + ₩10.4B operating profit in 2025. We analyze 5 risks — 84% Japan dependency, PER 52x, 67% lockup — and the entry checklist investors need.
+300%
Day-1 double-limit surge
₩504B
Market cap (May 14)
₩80B
2025 revenue
₩10.4B
2025 operating profit
PER 52x
4x sector average of 12x
84%
Overseas revenue from Japan
On May 14, 2026, Polred (487580) surged +300% on its KOSDAQ debut — hitting the daily price limit of ₩20,000 from an IPO price of ₩5,000. Market cap topped ₩504 billion in a single session.
The company began as a Hyundai Motor in-house venture in 2016 and spun off in 2019, building a profitable baby products business with ₩79.9B revenue and ₩10.4B operating profit in 2025. On the same day, Cosmo Robotics (listed May 11) hit +778% over 4 trading days — both are labeled Korea’s top 2026 new listings.
This analysis covers: company overview, the ₩80B growth story, 4 core products, 4 structural strengths, 5 risks (84% Japan dependency, PER 52x, 67% lockup), and an entry checklist for investors.
A Hyundai Motor in-house venture became a ₩500B KOSDAQ company in 7 years. — Polred IPO summary (May 14, 2026)
01 Company Overview: From Hyundai Spin-off to ₩500B
| Item | Detail |
|---|---|
| Ticker | 487580 (KOSDAQ) |
| Listing Date | May 14, 2026 (NH Investment & Securities) |
| IPO Price | ₩5,000 (top of ₩4,100–₩5,000 range) |
| IPO Size | ₩13B (2.6M shares) |
| CEO | Lee Hyeong-mu (former Hyundai Namyang R&D automotive designer) |
| Largest Shareholder | Lee Hyeong-mu 12.47% |
| Shares Outstanding | 25,182,861 |
| May 14 Result | Open ₩16,500 → Double-limit ₩20,000 (+300%) |
★ IPO Demand — Institutional book-build 1,486:1, retail subscription 3,169:1, deposit funds ~₩5.2T. Lock-up commitment: 66.06% by count / 67.24% by volume — extremely strong institutional conviction.
02 ₩80B Revenue: 3.5x Growth in Two Years
| Year | Revenue (₩B) | Op. Profit | Key Event |
|---|---|---|---|
| 2022 | ~₩23B | -₩0.5B | Losses continue |
| 2023 | ₩52.8B | ₩0.2B | First profitable year |
| 2024 | ₩52.8B | ₩6.2B | Ufang & IVG acquisition impact |
| 2025 | ₩79.9B | ₩10.4B | +51.4% / +68.1% ★ |
★ Two Growth Engines — ① 2024 bolt-on M&A (Ufang + IVG) + ② AIRLUV overseas expansion. Ufang revenue grew from ₩1.3B (2022) to ₩24B (2025) — ~18x. Baby Brezza grew from ₩7.6B at acquisition to ₩18.5B in 2025 — 2.4x.
03 Revenue Mix: The Japan 84% Trap
| Category | Revenue Share | Key Products |
|---|---|---|
| Baby Appliances | 53.3% | Ufang (sterilizer) + Baby Brezza (formula maker) |
| AIRLUV | 25.6% | Ventilated/heated seat cushions |
| Hygiene Products | 10.0% | Baby cosmetics etc. |
| Safety | 5.1% | Car seats (COVID impact contraction) |
| Other | 6.0% | Accessories |
| Market | % of Total Revenue | % of Overseas Revenue |
|---|---|---|
| Japan | 16.4% | 84% |
| Taiwan | 1.4% | 7% |
| Other (US, SE Asia) | 1.8% | 9% |
⚠ Core Risk — 84% Japan dependency means yen FX, consumption tax changes, Korea-Japan relations, and Japan’s birth rate decline all hit directly. Both Korea and Japan face declining birth rates — whether premium pricing can offset market contraction is the key long-term question.
04 Four Core Products — Category #1 Brands
| Product | Category | Key Metric |
|---|---|---|
| AIRLUV | Ventilated/heated baby seat | 1M+ units sold / 25.6% revenue |
| Ufang | Baby bottle sterilizer | 90%+ market share / ₩24B revenue (2025) |
| Baby Brezza | Formula maker | Korea & Japan exclusive / ₩18.5B revenue |
| Pixel / Franklin | Bottle washer / hygiene | Proprietary brand lineup |
05 Four Structural Strengths
- Multi-Category #1 Brand Portfolio — AIRLUV, Ufang, Baby Brezza, Pixel each lead their category. Diversified, not single-product dependent.
- Fully Vertically Integrated — In-house: product planning, design, manufacturing, logistics, CS/AS. Own mold design differentiates from Chinese import resellers.
- Bolt-on M&A Playbook — 100% acquired Ufang + IVG in 2024. Within one year, acquisitions represent 47.5% of revenue.
- VIB (Very Important Baby) Trend Alignment — Fewer babies but more spending per child. The premium baby products market is actually growing.
06 Five Risks — Honest Assessment
| Risk | Detail |
|---|---|
| ① PER 52.49x | 4x sector average of 12.84x. Limits further upside after +300% debut. |
| ② 84% Japan Dependency | 84% of overseas revenue from Japan alone — yen FX, policy, tariff exposure. |
| ③ Korea + Japan Birth Rate Decline | Both key markets shrinking — premium pricing strategy must offset volume decline. |
| ④ 67% Lockup | 67.24% of institutional shares locked — concentrated sell pressure at 1/3/6-month release. |
| ⑤ M&A Revenue Dependency | 47.5% of revenue from 2024 acquisitions — organic growth rate needs separate validation. |
07 Polred vs Cosmo Robotics — Same Day, Different Story
| Item | Polred (487580) | Cosmo Robotics (439960) |
|---|---|---|
| Listing | May 14, 2026 | May 11, 2026 |
| May 14 Close | ₩20,000 (+300%) | ₩52,700 (+778%) |
| Pattern | Day-1 double-limit | Double-limit + 3 consecutive limit-ups |
| Revenue (2025) | ₩79.9B (profitable) | ₩8.9B (loss-making) |
| Investment Type | Stability + Japan exposure | Growth + short-term frenzy |
★ The Key Difference — Polred is a profitable company (₩80B revenue, ₩10.4B operating profit) — a stability bet. Cosmo Robotics has ₩8.9B revenue with losses, but FDA certification and growth narrative. Completely different investment theses.
08 Entry Checklist — Five Signals
- STEP 1: Lockup Release Schedule — 67% institutional lockup. First major sell pressure arrives ~mid-September 2026 (18 weeks post-listing)
- STEP 2: PER 52x vs Sector 12x Justification — Can the 4x premium hold? Track overseas revenue growth rate continuity
- STEP 3: Japan Revenue FX & Policy Risk — 84% Japan exposure = yen, tariff, consumption tax, Korea-Japan relations all in play
- STEP 4: Organic Growth vs M&A Effect Separation — Strip out the 47.5% acquisition contribution; what does the underlying business grow at?
- STEP 5: US & Taiwan Expansion Progress — Ufang US launch / geographic diversification away from Japan dependency
★ Bottom Line — “No chasing. Wait for the premium to compress, then scale in — and check lockup dates first.” Polred is a profitable, structurally sound business. But PER 52x and 84% Japan concentration are real constraints at current prices.
09 Conclusion: How to Frame Polred
₩80B revenue, ₩10.4B operating profit — a real business. But PER 52x and 84% Japan dependency are real constraints.
Polred has genuine structural appeal: profitable at scale (₩80B/₩10.4B), four category-leading brands, fully vertically integrated operations. These are durable competitive advantages, not just IPO hype.
But entering immediately after a +300% surge demands caution. PER 52.49x is 4x the sector average, and 84% Japan concentration creates single-market risk. The September lockup expiry is the next major test.
① Strengths: ₩80B revenue + profitable / 4 category #1 brands / vertically integrated
② Risks: PER 52x vs 12x sector / Japan 84% / birth rate decline / 67% lockup
③ Key Variable: US/Taiwan geographic diversification / organic growth rate / Ufang global
④ Watch Dates: Mid-September lockup release / H1 2026 earnings / Japan revenue share
⑤ Entry Strategy: No chasing / scale-in approach / verify lockup schedule first
② Risks: PER 52x vs 12x sector / Japan 84% / birth rate decline / 67% lockup
③ Key Variable: US/Taiwan geographic diversification / organic growth rate / Ufang global
④ Watch Dates: Mid-September lockup release / H1 2026 earnings / Japan revenue share
⑤ Entry Strategy: No chasing / scale-in approach / verify lockup schedule first
🏠 Recommended Products
This post is part of the Coupang Partners program. A commission may be earned from qualifying purchases.
![[Breaking 21:30 KST] US April CPI 3.8% — oil spike kills Fed rate-cut bets](https://getdir.app/wp-content/uploads/2026/05/01_cpi_trend-768x380.png)
